| Reagan-Udall Foundation

Read more about Study to Investigate the Health Benefits of a Quercetin/Curcumin-Based Supplement for Mild to Moderate Long COVID-19 Symptoms

Read more about ECM Therapeutics, Inc.

We will share key learnings related to the design of our Phase 2b PRIZM study in MELAS at the primary mitochondrial diseases public workshop, hosted by the Reagan-Udall Foundation for the FDA.

Coverage

Read more about Tisento Therapeutics: Tisento Highlights Two Venues Advancing Patient-Focused Therapeutic Development for Mitochondrial Diseases

Read more about The COVID Dome Trial

Read more about Effect of Metabolic Modulation on a Post-acute COVID-19 Vaccination Syndrome (PACVS) Cohort

Read more about The Effect of Monocyte Values Accompanied by Lymphopenia on the Prognosis of Patients Diagnosed With COVID-19

Read more about Project COMET: Massed Prolonged Exposure for PTSD and SUD

Read more about Neurological Development In Toddlers After Maternal SARS-CoV-2 Infection During Pregnancy

Read more about The Role of Obesity in Severe COVID-19 Pathophysiology

Read more about Exploration of Pregnant Women's Reluctance Toward COVID-19 Vaccination

Subscribe to

(202) 849 - 2075

1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036

admin@reaganudall.org

Subscribe for updates from the Reagan-Udall Foundation for the FDA